➡ Dr. Bryan Ardis discusses a recent FDA decision to stop the prescription of a certain hypothyroidism medication that was benefiting 1.5 million Americans. The FDA instead favors two other approved drugs, one of which is Levothyroxine, currently used by 22 million Americans. However, a study funded by Taiwan’s Department of Health reveals concerning information about Levothyroxine. Dr. Ardis urges everyone to be aware of this situation, especially those who know someone taking Levothyroxine for thyroid conditions.
➡ The FDA initially expressed concerns about the safety of unapproved thyroid medications, lyothyronine and levothyroxine, taken by 22 million Americans. However, they later reversed their stance, promising to ensure access to these drugs. This change was influenced by the “Make America Healthy Again” movement’s focus on natural drugs. Despite this, a 2021 study from Taiwan raised concerns about the link between long-term use of levothyroxine and an increased risk of cancer.
➡ The article discusses a study that found a link between the use of the drug levothyroxine and an increased risk of cancer. The study, conducted in Taiwan, found that both short-term and long-term use of the drug, regardless of dosage, increased the risk of various types of cancer. The risk was particularly high for female patients. The author criticizes the medical community for prescribing such drugs, suggesting that the drugs may be causing the cancer rather than treating pre-existing conditions.
➡ Research shows that using levothyroxine, a common medication for underactive thyroid, can increase the risk of developing cancer by 50%. This risk applies to both men and women and includes various types of cancer such as brain, skin, pancreatic, and breast cancer. Therefore, patients and doctors should consider this risk when starting or continuing levothyroxine treatment for hypothyroidism. It’s important to share this information to help prevent early suffering and death from cancer.

Foreign Hi everybody, I’m Dr. Bryan Ardis and this is the Dr. Dr. Ardis Show. And I am really thrilled and honored to be hanging out with you today. And this is a very special, not calendared. It wasn’t put on a schedule for me to actually do this podcast in this review. This actually I’m going to give credit to someone else, someone I considered a hero. During the COVID 19 pandemic, a medical doctor out of Gulf Breeze, Florida named Dr. Deb Viglione. And yes, she’s still in practice and yes, anybody out there, I would trust her with my own life, my own wife, my own kids.

But Dr. Deb Biglione called me last week and this recording is occurring in the middle of August 2025. And she called me last week because she was really upset about something and because of my work with Remdesivir, her efforts. Also during the COVID 19 pandemic, she asked for my help. What she brought to my attention was shocking. All right, so what I’m about to show you is that in this month, August of 2025, the FDA on August 7th made an announcement and noted, put everybody on notice of a particular drug that’s being prescribed by medical doctors all across the United States that they could no longer prescribe a specific medication for hypothyroidism a under functioning thyroid disease.

The FDA decided that the prescription medication that 1.5 million Americans were benefiting from was no longer allowed to be prescribed in favor of two other FDA approved drugs instead that already 22 million Americans are on. So the notice went out by the FDA to all the manufacturers of the non FDA approved but prescribed by medical doctors drugs that 1.5 million Americans were benefiting from for their thyroid condition. On August 7, they put the manufacturers on notice and then they notified the medical doctors around the country that if you’re prescribing these drugs, we’ll give you time to get them off of them in favor of these two other drugs.

And then within seven days, on August 5th, sorry, August 14th, 2025, the FDA changed its tomb and reversed that decision. Now, within that week is when Dr. Deb Biglion had contacted me and said, we have got to get this information out. And then she shared a link to a study and I need to review that study with you. So everything you’re about to learn, it is extremely important that everybody in America and around the world knows what I’m about to show you. That was brought to my attention by the incredible internist medical doctor from Gulf Breeze, Florida.

Dr. Deb Viglione, who is standing firm on her Hippocratic oath to do no harm, and she is looking out for you. Now, what I have learned since reviewing this research study she was referencing. You’re about to find out why I thought it was so important that now this week I bring this information to all of you because you probably know somebody personal to you at work, at home and your family who’s on this medication that the FDA is trying to force everybody to go on to for thyroid conditions. If you or anybody out there has somebody who is on Levothyroxine or Synthroid, you need to be watching this presentation.

There is a generic drug called Levothyroxine and I’m about to show you some horrific information about levothyroxine that 22 million Americans are currently swallowing every single day as the number one recommended hypothyroid drug for all Americans. All right, you know how this works. I’m gonna actually show you a PowerPoint presentation. I’m going to show you the FDA’s announcements, some mainstream media, NBC News articles showing the reversal. And then I’m going to dive into a research study that was conducted, funded by the Department of Health in Taiwan just a couple years ago in 2021, on, on 800,000 people.

You’re going to be as shocked as I am. I hope you share this far and wide. And let’s get into it. I’m going to show you the PowerPoint and walk you through that. This should take less than an hour to get through. All right, so the title of this presentation is True or False. Levothyroxine increases the risk of developing many cancers. Remember, you can take your phones out, turn on the camera, put it, aim it at the screen. You see that QR code, Then tap the link, put in your email if you want to be notified.

When such alerts like this that are very important are being brought to our attention, you need to know. Dr. Deb Biglione thought this was important for me to know because she thought you should know and she knew I would tell you. All right, so here we go. Let’s dive in. This is, you’ll see, on the right hand side, you will see. This is the FDA’s August 7, 2025 announcement. Millions of Americans take thyroid hormone replacement medication to treat hypothyroidism. Currently, there are two types of thyroid hypothyroidism medicines on the market, available only by prescription. The most commonly used type of therapy is synthetic laboratory made medications containing only levothyroxine or lyothyrenine.

I don’t say that one very often. Leothyronine. We’re gonna focus on levothyroxine because it’s by far the most prescribed. An estimated 22 million patients receive prescriptions for levothyroxine dispensed by US outpatient retail pharmacies like CV, Walgreens, Walmart, Target in 2024. Levothyroxine or lyothyroidine. These medications have been FDA approved for decades. The FDA announcement wants everybody to know. The second type of therapy is animal derived thyroid medication and sometimes called desiccated chopped up thyroid extract or dte. These medications, the FDA wants you to know, are marketed as armor Thyroid. I’m sure you’ve all heard of these. NP Thyroid, Nature Thyroid and Natural thyroid, among other names.

They want you to know. These medications are produced from dried ground animal thyroid glands, usually porcine, which is pig, meaning from a pig. Animal derived thyroid medications are not FDA approved yet. An estimated 1.5 million patients received prescriptions for these medications from US outpatient retail pharmacies in 2024. The FDA’s concerns with unapproved thyroid medications. This is the next section inside that FDA document putting everybody on alert about these drugs for thyroid problems. FDA has concerns with the safety and effectiveness of the unapproved animal derived thyroid medications which have not been reviewed by the FDA to ensure safety, purity and potency and may have quality and dosing issues.

For example, I have to read these to you. Tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Oh, no. Inconsistent doses can have serious consequences for patients. Oh, no. Too much medication can cause unwanted effects and too little could not be effective. That’s true for all drugs weirdos. All right, what’s next? The next concern is this. Thyroid medications derived from animal thyroid glands have an increased risk of certain impurities due to the source being that they come from animal thyroid tissue or the way it is manufactured. These issues can lead to infections and other health concerns.

Before I even go any further, anybody out there ever seen FDA approved drugs? And law firms TV commercials telling you that these FDA approved drugs like Vioxx and others are creating horrible problems for you and now we can sue them all. How come that’s the case with FDA approved drugs? They’re telling you we have these concerns about these drugs because of the possibility that there might be manufacturing issues because they come from animals. Oh, really? The agency has received complaints. Okay, now we’re getting real. The agency has received complaints from patients and reports of adverse events related to the safety and potency of these unapproved medications.

Have you, do you know anybody that’s written into the FDA and went I’m not sure these drugs are potent enough? I’m not really sure that’s the reason. Remember the issue is they’re going after non FDA approved drugs because they’re from nature. You can’t, you can’t patent those and get them FDA approved yet. Least these drugs. But there are in favor synthetic lab created unnatural substances that are FDA approved that 22 million Americans are actually taken right now. So let’s make sure we take the other 1.5 million people that are on the natural thyroid gland medications being prescribed by MDs all over the country.

And let’s make sure we convert those 1.5 million prescribe patients with nature throid armor thyroid. Let’s make sure we convert them to levothyroxine drug users and this is what you need to know. The FDA’s actions to protect their patients. In this FDA alert dated August 7, 2025, FDA sent letters to manufacturers, importers and distributors of marketed unapproved animal derived thyroid medications on August 6, 2025. This letter notified them of the agency’s intent to take actions against unapproved animal derived thyroid medications. Doctors will be able to work with their patients to safely transition them to an FDA approved thyroid hormone replacement medication.

Thank God. I trust the fda. Currently I’m going to remind you there are two, we’re going to go back. There are two types of thyroid hormone replacement medicines on the market available only by prescription and they are called, we’re going to highlight this one, levothyroxine, which is what they’re in favor of. These medications have been FDA approved for decades. There’s the pictures of lyothyronine and levothyroxine. These are the two drugs 22 million Americans are taking right now. Now this is NBC News and It’s actually dated August 14th, exactly seven days after that FDA letter. The FDA warns about unapproved thyroid pills, then says it’ll ensure access to them.

Wait, what? I thought they said they were taking it away. And put all the manufacturers and doctors on notice. And then you read the subtitle of this article. The apparent reversal illustrates the power of the make America Healthy Again movement, particularly with its focus on natural drugs. Now to show you the date. There’s the date. August 14th, 2025. Now I’m just going to read these few paragraphs from here so you understand what NBC is reporting to Everybody about this FDA notice a week earlier, an unusual about face that played out at the Food and Drug Administration over the last week illustrated the power of the, quote, make America healthy again movement, particularly with its focus on natural drugs.

Last Thursday, the agency published a statement saying it had concerns about the safety and effectiveness of unapproved thyroid medications made from animal tissue after it received complaints from patients and reports of adverse events. Oh, how come they didn’t pull the COVID 19 vaccines when there was thousands and thousands and thousands? Over 30,000 reported killed within 48 hours of receiving the COVID 19 vaccines and they didn’t pull that? There were lots of concerns reported to the government. Why didn’t they pull that? Why are they pulling this natural thyroid medication for hypothyroidism? All right, so here we go after as.

Okay, let’s just keep reading. Sorry, I like to jump ahead in my thoughts. All right, so last Thursday. I’ll just continue. The agency published a statement saying it had concerns about the safety and efficacy of unapproved thyroid medications made from animal tissue after it received complaints from patients and reports of adverse events. As a result, the FDA said it had notified drug makers of its intent to take action against the products, but added that it wouldn’t be so immediately to give patients time to switch their medications. But On Wednesday evening, FDA Commissioner Marty McCary seemingly reversed course, writing in a post on X that the FDA was committed to pursuing the first ever approval of desiccated thyroid extract, pending results of the ongoing clinical trials.

Wait, wait, wait. What? They didn’t say this a week earlier in the FDA statement. In the meantime, he says we will ensure access for all Americans. He wrote. So what’s the big deal? I’m going to show you the massive, deadly and cancerous deal known by the FDA that is linked to short term and long term use of the FDA approved drug called levothyroxine. That was brought to my attention by the incredible internist, M.D. herself, Dr. Deb Viglione, M.D. here’s the drugs, levothyroxine that they’re trying a week earlier to push all medical doctors to be forced to only prescribe these drugs for thyroid problems that 22 million people are already on.

This is the study that Dr. Deb de Leon had referenced. And then I had to go find. I couldn’t believe she was telling me. I was like, wait, what? I gotta go look this up. I did not know this. So you are seeing this for the first time. I just read this last week. I just built out this PowerPoint for all of you to have access to this information it is at the Dr. Ardis show under the Resources tab you can download this PowerPoint you better share this and you better keep paying attention because someone you know I guarantee you is on this drug Levothyroxine all right now in this research study from 2021, Levothyroxine is a widely prescribed medication for the treatment of an underactive thyroid.

I need to go back. Let’s read the title again. The title of this 2021 study is this Risk of Cancer in Long Term Levothyroxine Users to investigate the magnitude of the possible association between levothyroxine use and cancer risk, this retrospective case control study was conducted using Taiwan’s Health and Welfare Data Science center database. Cases were defined as all patients who were older than 20 years old and had a first time diagnosis for cancer at any site in their body for the period between 2001 and 2011. You had to be older than 20 on levothyroxine or slash Synthroid for any period and any cancer diagnosis given to you between the years 2001 and 2011 in the introduction part of this research study.

Thyroid disease, it is noted, is a major public health concern worldwide. The number of individuals with thyroid disorders is expected to continue to grow, having reached approximately 750 million globally in 2012. I’m sure it’s much higher than that now. There’s only supposedly roughly 8 million people. This is roughly 1/8 of the world has hypothyroidism. Imagine the profits that could be reaped by the companies that make levothyroxine Synthroid. Imagine if we could force all Americans who consume more drugs than any other country in the whole world. Imagine if we got all of them to be on levothyroxine.

Levothyroxine is a first line treatment for hypothyroidism. Recently, concerns have been raised regarding the use of levothyroxine medication and its adverse effects, for example on bone health and heart function. Despite clinical benefits, levothyroxine concern about its overall safety has further been raised because of its connection to cancer risk. Several disease progression studies have attempted to assess the magnitude of the association between levothyroxine use and cancer risk, but their findings have been inconclusive. Cornelli and his team, other researchers, reported in a study correlation between levothyroxine and its increased risk of lung cancer. However, long term use of levothyroxine they found in that study was associated with a reduction in risk of colorectal cancer.

So they found an increase in lung cancer but a decrease in colon cancer. So that’s kind of confusing for researchers and medical scientists. Biological studies have also analyzed the association between levothyroxine and cancer risk. Some studies have found that such association is linked to increased oxidative stress resulting from the overproduction of ROS in the body. Increased inflammation and oxidative stress is considered the main factor for various chronic conditions such as cancer and autoimmunity. They’re telling you they’ve linked in other studies, biological studies that levothyroxine increases oxidative stress, which is what is linked to cancer diagnosis and autoimmune diseases.

That’s already been done in previous studies. They’re letting you know. So these researchers for the study in Taiwan in 2021 on levothyroxine use long term and short term. This is why they’re doing this study. These are the reasons they’re given to you as the reader. Owing to insufficient biological evidence and inconclusive results from other disease process studies, we conducted a nationwide population based case control study to observe whether long term use of levothyroxine is associated with an increased risk of cancer. Is it really a correlation between how long people are on levothyroxine and their risk of developing cancer? Health and Welfare Taiwan the National Health Insurance covers more than 99% of the 23 million inhabitants of Taiwan who receive all forms of their healthcare services, which includes outpatients, inpatient care, Chinese traditional medicine, dental care, childbirth, physical therapy, preventative health care, home care and rehab for chronic mental illness.

This database also contains information on 99% of all the people in Taiwan regarding patient demographic characteristics, which encrypts patient identification numbers, birth dates and sex, and inpatient or outpatient data which includes prescription drugs. They’re on diagnosis, medical diagnosis and pharmacy records. Furthermore, specific data on those medications prescribed, laboratory and diagnostic tests, dates of their visits, length of their hospitalization stays and their diagnoses are stored. Based on the International Classification of diseases, the ninth revision of the Clinical Modification ICD9 code book and Reference, this study retrieved and analyzed data between 2001 and 2011 which offered a great opportunity to explore the relationship between lemothyroxine use and the risk of cancer.

They’re telling you hardly any other country has this much data on almost 100% of their population and are keeping track of almost every aspect of their medical health histories than Taiwan. This is why we’re looking at it. Try to clear this whole confusing this information that’s been confusing to other researchers. Can we see a country with all their medical health data for all of their population? Can we see that there really is a correlation between levothyroxine prescriptions, them picking them up at the pharmacy, them swallowing them, them taking them every day, and then eventually being diagnosed with cancer soon after or long after? In section 2.3 cases and controls were regarded as levothyroxine users if they were prescribed with levothyroxine for at least two months within the last three years prior to the index date.

This three year baseline period that they are reviewing, they’re going to look at a three year window of time. You guys, I cannot believe this. This statement is so important about to blow it up and isolate it. So please use your common sense when reading this statement. This three year baseline period was introduced because the use of certain drugs is known to increase within three years prior to a cancer diagnosis. I will repeat that here in a second. And then they go on to say this asinine statement most likely because of early symptoms related to a yet undetected cancer.

All right, it’s time to blow that statement up and let’s just look at this one statement. Don’t look at anything else. This is in relationship to levothyroxine use and cancer diagnosis. They chose a three year window of time from starting to take levothyroxine. This three year baseline period was introduced because of the use of certain drugs prescribed. FDA approved medications is known to increase. New prescription drugs is known to increase within three years prior to a cancer diagnosis. What did you know that the medical profession and the FDA and NIH and all these groups know that there are certain drugs people are prescribed and within three years they see an increased risk of being diagnosed with cancer.

But look at the researchers reasoning that they’re quoting from all these pharmaceuticals and medical journals. It’s most likely due this three year window of time from being given drugs to being diagnosed with cancer. They’re saying it’s most likely those drugs were being prescribed to these individuals three years before their cancer diagnosis because of early symptoms the patients had related to a yet undetected cancer. They’re giving you the excuse that the people being prescribed these certain drugs and then being diagnosed with cancers three years later isn’t because the drugs that people have been swallowing for these three years leads to them developing cancer.

They’re saying it’s most likely because the symptoms that the patient went in with and then was put on these drugs for was because of symptoms related to a yet undiagnosed cancer that they would only find three years later. Come on people. I hope my audience has more common sense than this. Correlation can equal causation. You start taking these certain drugs that lead to a cancer diagnosis, three years later, it’s most likely the drugs are causing the cancer, not the other way around. Can’t tell me these people have high blood pressure, low blood pressure, thyroid problems, go in because they’re fatigued.

They, they go in, they’re put on levothyroxine, then within three years they’re diagnosed with cancer. And then they’re going to tell you, oh, it’s because they had cancer that just wasn’t detected three years earlier. That’s why they retired and put on levothyroxine. Oh my God, please don’t fall for this medical bullcrap. The use of certain drugs, just hammer this into your brain. The use of certain drugs, I just shortened the sentence. Is known to increase within the three years prior to a cancer diagnosis. Drugs are known to cause cancer, FDA approved, prescribed by medical doctor. Drugs are known to increase the diagnosis of cancer.

And there’s certain drugs within three years that do that. And they know it to be valid. For this research study, levothyroxine users, their prescription dates, their daily doses and duration of levothyroxine use were extracted from the Taiwan’s database. Each patient who had developed cancer was matched for age, sex and index date with four subjects who had never been diagnosed with any cancer. The cumulative duration was measured among the levothyroxine users and they broke it down into two categories of patients. They’re going to have short term levothyroxine prescription use and long term, short term users. Group A is two months to one years only of taking and swallowing levothyroxine for an under functioning thyroid.

So you got short term users or two months of using it to one years. And then there’s long term users. Those are those that have been taking levothyroxine for longer than one year. Doses in this study were standardized. They’re going to divide this down to three groups of people. They want to know is their low dose, middle dose, high dose of levothyroxine. They’re going to figure out a range. They’re going to call low dose, medium and high. And then they’ve got those two categories. Those short term uses and long term doses in the study were standardized by dividing levothyroxine users overall 3 year dose and then dividing that by 0.15mg a patient’s 3 year average daily dose was then calculated by dividing the three year total number of daily dose in by 1095 days, which is three years.

Based on the three year average daily dose, the patients were categorized into three groups. Those taking less than 0.34 milligrams and then those 0.34 to 0.67 milligrams a day and then above 0.67. And then this statement is in every research study a P value greater than 0.05% was considered statistically significant. If there is a difference between any of these groups, the controls, those taking levothyroxine and them, not any of the doses, any of the short term, long term categories of patients. If there is a change of 5% or more, we’re going to consider that a significant correlated increased risk factor for cancer regardless.

So that’s how they set up the study. The relationship between levothyroxine use and cancer risk is shown in table two. You’re gonna see it here in a second on the right. The results indicated that levothyroxine use increased the risk of overall cancer when compared with non users of levothyroxine. I repeat, the results indicated that levothyroxine use increased the risk of overall cancer when compared with those who were not on levothyroxine for the same three year period. There’s table two. I’m going to zoom in here in a second. You have to see this next statement. There were also significantly more than 5%.

There were also significantly increased risk of brain cancer, skin cancers, pancreatic cancers, prostate cancers, female breast cancers, bladder cancers, lung cancers and colon cancers with the levothyroxine use in the cases compared to the controls. Now I’m going to delete all the numbers in between and show you what it what that sentence looks like without all those numbers and let’s read it again together. There were also significantly increased risk of brain, skin, pancreatic, prostate, female breast, bladder, lung and colon cancers with the levothyroxine use in the cases compared to the controls. Here’s table 2. At the top you’ll see levothyroxine use and risk of cancer.

I put at the top above the graph the quote these were that are highlighted. There was a significantly increased risk of cancer. Not just they saw an increase, it was above 5% which is the benchmark for all research studies in medicine and science forever. Now I just highlighted which ones were significant on that chart. You see them in order. Colon cancer, prostate cancer, lung, skin, female breast, prostate, bladder, Brain. Ask your doctor if cancer is right for you when they prescribe levothyroxine. I just blew up the table for you so you can see them all. Now.

Let’s look at Table 3 in the research study from Taiwan. Table 3 shows the risk of cancer in male and female patients. Pay attention y’. All. Female patients treated with levothyroxine had a relatively high risk of overall cancers as opposed to their male counterparts. Females, you’re more at risk. There was seen an increased risk of bladder, lung, pancreatic and esophageal cancers were also identified in female patients using levothyroxine. Let’s delete all the numbers so it’s easier to read. There was seen increased risks of bladder, lung, pancreatic and esophageal cancers were also identified in female patients using levothyroxine.

Here is Table 3. Table 3 shows the risk of cancers associated with levothyroxine stratified by gender. You will see the ones that are highlighted. Esophageal, pancreatic, lung, bladder that had a statistically increased risk more than males. Table 4 shows this effect of cumulative duration. How long did you take it? Short term, long term. All right. Shows the effect of cumulative duration of levothyroxine use in cancer risk. Short term use from 2 months to 1 year and long term use greater than 1 year of using levothyroxine were significantly associated with overall cancer risk. It didn’t matter if you took it for less than a year or longer than a year.

Your overall risk of being diagnosed with a new cancer for both of you goes up significantly. Short term and long term use of levothyroxine were significantly associated with overall cancer risk. Ask your doctor if short term or long term prescriptions of levothyroxine are right for you. And then sue the FDA for trying to force everybody for for being put on this cancer causing drug in favor of a cancer causing drug over a natural thyroid gland extract. Let’s continue. Table 4. Patients using levothyroxine for more than one year were observed to have higher risks of brain, breast, bladder, lung and gastric cancer.

Stomach cancers specifically if you took it for longer than one year. Patients using levothyroxine for more than one year were observed to have higher risks of brain cancer, breast cancer, bladder cancer, lung cancer and stomach cancers. And I highlight them for you on the screen. Table 5 represents the effects of three year average daily dose of levothyroxine use on cancer risk. So now we’re just going to look for people that are on it for an average of three years, Daily doses were categorized into these three groups. Low dose, medium and high doses. Low, medium and high doses of levothyroxine use all showed a higher risk of overall cancer.

So if you’re out there thinking, well I’m on a lower dose, oh no, I’m in a higher dose, oh wait, I’m in the medium group, it didn’t matter, you still are at a higher risk of developing cancer within three years. Low, medium and high doses of levothyroxine use all showed a higher risk of overall cancer. Ask your doctor if cancer is right for you when they prescribe levothyroxine. Table 5 represents the effects levothyroxine use on cancer risk. Just highlighting it there to the right you will see based on average daily dose, it didn’t matter. There’s all the cancers that have a higher risk within three years, no matter the dose.

So don’t tell me less is better, more is better. Nope. Poison is poison now compared to other studies in the past. I like looking at this. In the same research study from Taiwan, a Swedish large scale cohort study indicated an association between levothyroxine use and increased risk of cancers as follows. The overall cancer risk in both gen, both genders risk of breast, endometrium, genital bladder, skin cancers in leukemia in females and the risk of thyroid and other endocrine cancers in males. That’s what they found. This study. I’m just showing you the study number 36 they’re referencing.

I just want to show you what the title is. The title is there. I’m going to highlight it for you. This is what was found in Sweden and this is the title of their paper. I just want to show you. Levothyroxine treatment is associated with an increased relative risk of overall an organ specific incident cancers. A cohort study of the sweetest population published in Cancer Epidemiology Epidemiology in the year 2020, just a year earlier. Ask your doctor if levothyroxine is right for you because it doesn’t matter what country they’re looking at. Those on level with thyroxine have an overall increased risk, male and female, for cancers of all kinds.

I’m showing them to you. In the current study we additionally included the risk of brain cancer which was not analyzed in the Swedish study. They didn’t even look for that. In conclusion, researchers of the Taiwan research study in 2021, our study finds showed that levothyroxine use is associated with increased risk of cancer and should be taken into consideration in initiating and renewing levothyroxine therapy for patients with hypothyroidism. Our study findings showed that levothyroxine use is associated with increased risk of cancer and should be taken into consideration in initiating and renewing levothyroxine therapy for patients with hypothyroidism.

These research studies are telling all medical doctors out there and you patients included doctors, if you’re going to prescribe levothyroxine, you should understand and make your patients aware there is an increased risk of cancer. For every time you write this prescription and they fill it, you’re welcome. This is the summary at the top of the research study. I didn’t show you yet. Levothyroxine is widely prescribed medication for the treatment of an underactive thyroid. This just summarizes everything in the paper I just showed you and some of these statements need to be shown. A total I mentioned earlier, 800,000 patients, that’s how many they started with.

And they whittled IT down to 600. A total of 600,000 cases and 2 million controls were included in this current study. It’s a lot of people. Levothyroxine users showed a 50% higher risk of cancer at any site in their body. So for those of you out there who are watching the medical programming called television shows and you’re seeing all the shows telling you how to be scared of cancer, be worried about cancer and driving into your brain that it’s a genetic problem and everybody’s at the same risk. No you on prescription drugs, including levothyroxine, those of you being prescribed drugs for an under functioning thyroid, you are at a 50% higher risk of developing all cancers from the drug compared with non users of levothyroxine.

So those of us walking around not using that and taking things like selenium, iodine and l tyrosine amino acid to make our own natural thyroid hormones, we’re at less risk than you are on the FDA approved drugs. Significant increased risk were also observed for brain cancer, skin cancer, pancreatic cancer and female breast cancer. Oh my God. I guess broncha1, broncha2 genes. For all you women out there that have been programmed to be afraid, you’ve inherited Broncha1, Broncho2 genes. Did you know that levothyroxine increases significantly your risk of developing breast cancer without genetics, it doesn’t matter if you have those genes or not.

A total of 600, 1,733 cases and 2,500,000 controls were included in the current study. Levothyroxine users showed a 50% higher risk of cancer at any site compared with the non users. Significant increased risks were also observed for brain cancer, skin cancer, pancreatic cancer and female breast cancer. Our study results showed that levothyroxine was significantly associated with an increased risk of cancer, particularly brain, skin, pancreatic and female breast cancers. Are you listening to me? I keep repeating it on purpose. When your MD recommends levothyroxine for hypothyroidism, ask your doctor this question. Hey doc, which cancer do you think is right for me? If you want this PowerPoint scan the QR code, go to the resources tab of the Dr.

Ardis show if you want to be notified when there’s things being published in the media that you can’t wrap your head around. Why the FDA might be doing this? Why are they recanting this? What’s so significant about the 22 million people on level with thyroxin? Why are they trying to force all doctors to prescribe this one and only drug? To prescribe levothyroxine to the other 1.5 million Americans increases the risk of becoming diagnosed with cancer. Are you starting to put together how this benefits the FDA and big pharma? Who’s the largest bribe money paying lobbying money to the federal government, including the fda.

Are you starting to figure out why the FDA is being told to ban the natural natural products for thyroid problems versus levothyroxin, the synthetic FDA approved drug. It feeds the cancer revenueing engine of that industry. Remember you get my book Moving beyond the COVID 19 Lies. In that book you’re going to learn also some technology since 1956 that they know creates cancer rapid turbo cancers funded by the nih and they’ve known it ever since. All right, let’s back out of here. I would like to personally thank the medical doctors around the world who were moved when the FDA tried to do this and knew the information about this population study that was done in 2021.

Anybody out there who’s been prescribed levothyroxine Synthroid? Anybody out there who actually knows anybody who’s on these drugs, Please for the love of God, share this information with them. There’s nothing more demoralizing than to see people’s lives end early suffer early suffer long. When being treated and being diagnosed with cancer. All of you are being programmed that we don’t know what causes cancer. I just showed you what they know increases all cancer risk. For females and males by 50%. The drug FDA approved called Levothyroxine. I’m Dr. Bryan Ardis. This is a special presentation for you. Please share this far and wide.

You’ve been put on alert. You’ve been warned. God bless. We’ll see you next time.
[tr:tra].

See more of The Dr. Ardis Show on their Public Channel and the MPN The Dr. Ardis Show channel.